You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 126 No. 4, April 1991 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLE
 This Article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Suppressive effects of visceral tumor on the generation of antitumor T cells for adoptive immunotherapy

V. K. Sondak, P. D. Wagner, S. Shu and A. E. Chang
Department of Surgery, University of Michigan Medical Center, Ann Arbor 48109-0331.

Antitumor reactive cells can be generated from lymphoid organs of mice bearing subcutaneous (SC), but not liver or lung, tumors by in vitro sensitization with irradiated tumor and interleukin 2. To examine whether visceral tumors mediated tumor-induced suppression, in vitro sensitization cells were generated from mice bearing SC tumors with and without concomitant liver or lung tumors. Antitumor efficacy of these cells was assessed in adoptive immunotherapy experiments. The presence of visceral tumors suppressed the ability to generate therapeutic in vitro sensitization cells from mice with SC tumors. By establishing visceral tumors at different intervals in relationship to SC tumor inoculation, we found that visceral tumor appeared to suppress directly the development of a host immune response to SC tumor, rather than inhibit function of established immune cells. Our model affords a means to study mechanisms of tumor-induced immunosuppression.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A Pilot Study of Consolidative Immunotherapy in Patients with High-Risk Pediatric Sarcomas
Mackall et al.
Clin. Cancer Res. 2008;14:4850-4858.
ABSTRACT | FULL TEXT  

Tumor-Induced Immune Suppression of In vivo Effector T-Cell Priming Is Mediated by the B7-H1/PD-1 Axis and Transforming Growth Factor {beta}
Wei et al.
Cancer Res. 2008;68:5432-5438.
ABSTRACT | FULL TEXT  

Tumor lysate-pulsed dendritic cells can elicit an effective antitumor immune response during early lymphoid recovery
Asavaroengchai et al.
Proc. Natl. Acad. Sci. USA 2002;99:931-936.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1991 American Medical Association. All Rights Reserved.